MLS000544460, an allosteric Eya2 inhibitor, has been developed and inhibited migration of human epithelial cell line [215], and further investigation about effectiveness of MLS000544460 in GBM treatment is awaited. The gene discussed is EYA2; the disease is glioblastoma.